secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2022-05-13T23:59:59+00:00
Accession:  0001723128-22-000019
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amneal stockholders elect all 10 director nominees, approve say-on-pay and auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- All 10 director nominees elected; Chintu Patel received highest votes (236,380,089 for).
- Say-on-pay advisory vote approved: 236,202,110 for, 1,193,006 against.
- Ratification of Ernst & Young as auditor for FY2022 approved: 256,967,689 for, 253,537 against.
- Broker non-votes were 20,029,960 on director elections and say-on-pay; none on auditor ratification.
- Annual meeting held May 9, 2022; all three proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000172312822000019/0001723128-22-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000172312822000019/amrx-20220509.htm
  HTML page:      https://secwatch.observer/filing/0001723128-22-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer